The α2,8-sialyltransferase 6 (St8sia6) localizes in the ER and enhances the anchorage-independent cell growth in cancer.


Journal

Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516

Informations de publication

Date de publication:
11 06 2022
Historique:
received: 21 03 2022
accepted: 27 03 2022
pubmed: 8 4 2022
medline: 29 4 2022
entrez: 7 4 2022
Statut: ppublish

Résumé

Sialylation, the final stage of post-translational modification of proteins, is achieved in the Golgi apparatus and is related to the malignant phenotype of cancer. Disialylation of ganglioside (GD3) by St8sia1 and polysialylation by St8sia2 and 4 have been shown to be related to malignant phenotypes; however, di/oligosialylation by St8sia6 is still unknown. In this study, we analyzed the malignant phenotype of St8sia6 and found that upregulation of St8sia6 in melanoma B16 cells increased anchorage-independent cell growth, which was not due to sialic acid cleavage by a sialidase. Moreover, unlike other sialyltransferases, St8sia6 localized to the endoplasmic reticulum (ER). We found that the localization to the Golgi apparatus could be regulated by swapping experiments using St8sia2; however, the malignant phenotype did not change. These data demonstrate that the enhancement of anchorage-independent cell growth by St8sia6 is not due to its localization of ER, but is due to the expression of the protein itself.

Identifiants

pubmed: 35390672
pii: S0006-291X(22)00491-0
doi: 10.1016/j.bbrc.2022.03.146
pii:
doi:

Substances chimiques

Gangliosides 0
Sialyltransferases EC 2.4.99.-
ST8SIA6 protein, human EC 3.4.99.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-58

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Rina Hatanaka (R)

Bioscience and Biotechnology Center, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya, 464-8601, Japan.

Erino Araki (E)

Bioscience and Biotechnology Center, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Integrated Glyco-Biomedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Chikusa, Nagoya, 464-8601, Japan.

Masaya Hane (M)

Bioscience and Biotechnology Center, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Integrated Glyco-Biomedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Chikusa, Nagoya, 464-8601, Japan.

Shiori Go (S)

Bioscience and Biotechnology Center, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Integrated Glyco-Biomedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Chikusa, Nagoya, 464-8601, Japan.

Di Wu (D)

Bioscience and Biotechnology Center, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Integrated Glyco-Biomedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Chikusa, Nagoya, 464-8601, Japan.

Ken Kitajima (K)

Bioscience and Biotechnology Center, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Integrated Glyco-Biomedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Chikusa, Nagoya, 464-8601, Japan.

Chihiro Sato (C)

Bioscience and Biotechnology Center, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya, 464-8601, Japan; Integrated Glyco-Biomedical Research Center (iGMED), Institute for Glyco-core Research (iGCORE), Nagoya University, Chikusa, Nagoya, 464-8601, Japan. Electronic address: chi@agr.nagoya-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH